Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions including the anti-idiotypic monoclonal antibodies

Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions including the anti-idiotypic monoclonal antibodies

US Patent 6491914 · Granted Dec 10, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for the treatment of malignant and infectious chronic diseases2013
Pharmaceutical compositions capable of inducing apoptosis in tumour cells, usefu2013
Preparations that potentiate immunogenicity in low immunogenic antigens2010
Monoclonal anti-idiotypic antibodies (AB2) and their uses2002
Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactos2002
Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotyp2000
Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotyp2000
Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotyp2000
Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotyp2000
Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotyp2000
Vaccine composition comprising autologous epidermal growth factor or a fragment 1999